GS3-007a dry suspension

DRUG2 trials

Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd.

Conditions

Adult Growth Hormone Deficiency (AGHD)Pediatric Growth Hormone Deficiency

Phase 1

A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)

RecruitingNCT07264595

Changchun GeneScience Pharmaceutical Co., Ltd.Pediatric Growth Hormone Deficiency

Start: 2026-01-18End: 2030-11-01Target: 88Updated: 2026-09-16

Phase 2

A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)

TerminatedNCT07259564

Changchun GeneScience Pharmaceutical Co., Ltd.Adult Growth Hormone Deficiency (AGHD)

Start: 2025-12-19End: 2026-05-12Updated: 2026-05-22